Larvol Delta - ASLAN-Pharmaceuticals-Announces-Three-Abstracts-Highlighting-New-Eblasakimab-Data-Have-Been-Accepted-as-EPosters-at-the-31st-European-Academy-of-Dermatology-and-Venereology-EADV-Congress

eblasakimab (ASLAN004) - ASLAN Pharma

https://www.globenewswire.com/news-release/2022/08/11/2496587/0/en/ASLAN-Pharmaceuticals-Announces-Three-Abstracts-Highlighting-New-Eblasakimab-Data-Have-Been-Accepted-as-E-Posters-at-the-31st-European-Academy-of-Dermatology-and-Venereology-EADV-C.html

Aug 11, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next